Premium Nahrungsergänzungsmittel | artgerecht

Vasculogenesis Factor – Definition and Significance

Vasculogenesis factors are signaling molecules that control the formation of new blood vessels from precursor cells. They play a key role in embryonic development and tissue regeneration.

Regular tips about health Regular tips about health

Things worth knowing about "Vasculogenesis Factor"

Vasculogenesis factors are signaling molecules that control the formation of new blood vessels from precursor cells. They play a key role in embryonic development and tissue regeneration.

What Is a Vasculogenesis Factor?

A vasculogenesis factor is a biological signaling molecule – typically a protein or growth factor – that regulates the process of vasculogenesis. Vasculogenesis refers to the de novo formation of blood vessels from undifferentiated precursor cells known as angioblasts or endothelial progenitor cells (EPCs). This process is fundamentally different from angiogenesis, in which new vessels sprout from pre-existing blood vessels.

Vasculogenesis factors are particularly active during embryonic development, where they coordinate the establishment of the primary vascular network. In modern medicine, they are also of great importance in the context of wound healing, tumor biology, and regenerative medicine.

Key Vasculogenesis Factors

Several molecules are considered central vasculogenesis factors. The most important include:

VEGF (Vascular Endothelial Growth Factor): The most well-known vasculogenesis and angiogenesis factor. It binds to specific receptors on endothelial cells and promotes their proliferation, migration, and survival.
FGF (Fibroblast Growth Factor): Promotes the differentiation of mesodermal cells into angioblasts and supports early vessel formation.
PDGF (Platelet-Derived Growth Factor): Involved in the maturation and stabilization of newly formed vessels by recruiting pericytes and smooth muscle cells.
Angiopoietin-1 and Angiopoietin-2: Regulate vessel maturation and stability through the Tie-2 receptor.
SCF (Stem Cell Factor) and SDF-1 (Stromal Cell-Derived Factor 1): Mobilize endothelial progenitor cells from the bone marrow and direct them to sites where new vessels are needed.

Mechanism of Action

Vasculogenesis factors typically act through specific receptor tyrosine kinases on the surface of target cells. Upon binding of the factor to its receptor, intracellular signaling cascades are activated that trigger the following processes:

Proliferation of endothelial progenitor cells
Migration of cells to the site of new vessel formation
Differentiation into mature endothelial cells
Formation of tubular structures (lumen formation)
Stabilization of the newly formed vessel

Role in Embryonic Development

During early embryonic development, angioblasts first form a primitive capillary network known as the primary vascular plexus. Vasculogenesis factors coordinate the spatial and temporal differentiation of this network. Mutations or loss-of-function events in genes encoding these factors frequently lead to severe developmental defects or are incompatible with life.

Clinical Relevance

Tumor Biology

Tumors depend on an adequate blood supply and therefore produce large amounts of vasculogenesis factors – particularly VEGF. This enables tumor growth and metastasis. On this basis, anti-angiogenic therapies have been developed that specifically inhibit vasculogenesis and angiogenesis factors to halt tumor growth.

Regenerative Medicine

In regenerative medicine and tissue engineering, vasculogenesis factors are used to promote the vascularization of artificial tissue constructs or to enhance the healing of poorly perfused wounds. Targeted delivery of growth factors is an active area of research, particularly for chronic wounds, diabetic ulcers, and ischemic conditions.

Cardiovascular Disease

In conditions such as myocardial infarction or peripheral arterial occlusive disease, therapeutic angiogenesis and vasculogenesis are being investigated as treatment strategies to stimulate new blood vessel growth in underperfused tissue.

Diagnostic and Therapeutic Significance

The detection of specific vasculogenesis factors in blood or tissue can serve as a biomarker for various diseases. Elevated VEGF levels, for example, are observed in certain cancers, rheumatoid arthritis, and diabetic retinopathy. Therapeutically, inhibitors of these factors – such as bevacizumab (an anti-VEGF antibody) – are used in oncology and ophthalmology.

References

Risau W. - Mechanisms of angiogenesis. Nature. 1997;386(6626):671-674.
Carmeliet P. - Angiogenesis in life, disease and medicine. Nature. 2005;438(7070):932-936.
Ferrara N., Gerber H.P., LeCouter J. - The biology of VEGF and its receptors. Nature Medicine. 2003;9(6):669-676.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.